Genmab A/S Files Form 6-K for April 2025
Ticker: GNMSF · Form: 6-K · Filed: Apr 14, 2025 · CIK: 1434265
| Field | Detail |
|---|---|
| Company | Genmab A/S (GNMSF) |
| Form Type | 6-K |
| Filed Date | Apr 14, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: reporting, sec-filing
TL;DR
Genmab filed a 6-K on 4/14/25, standard reporting, incorporated into S-8s.
AI Summary
Genmab A/S filed a Form 6-K on April 14, 2025, to report information for the month of April 2025. This report is incorporated by reference into several of Genmab's S-8 registration statements, including File No. 333-284876.
Why It Matters
This filing indicates ongoing reporting requirements for Genmab A/S, ensuring transparency for investors regarding its corporate activities and regulatory compliance.
Risk Assessment
Risk Level: low — This is a routine filing that incorporates previous information and does not introduce new material risks.
Key Players & Entities
- Genmab A/S (company) — Registrant
- 333-232693 (dollar_amount) — S-8 Registration Statement File Number
- 333-253519 (dollar_amount) — S-8 Registration Statement File Number
- 333-262970 (dollar_amount) — S-8 Registration Statement File Number
- 333-277273 (dollar_amount) — S-8 Registration Statement File Number
- 333-284876 (dollar_amount) — S-8 Registration Statement File Number
FAQ
What type of SEC filing is this?
This is a Form 6-K report of Foreign Private Issuer.
Who is the filer of this report?
The filer is Genmab A/S.
What period does this report cover?
This report is for the month of April 2025.
What is the filing date of this report?
The filing date is April 14, 2025.
How is this report being used in relation to other filings?
This report is incorporated by reference into Genmab A/S's registration statements on Form S-8.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on April 14, 2025 regarding GENMAB A/S (GNMSF).